These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1816241)

  • 1. Plasmapheresis in acute attacks of multiple sclerosis: the cons.
    Rostami AM
    J Clin Apher; 1991; 6(4):205-6. PubMed ID: 1816241
    [No Abstract]   [Full Text] [Related]  

  • 2. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R
    Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis in acute multiple sclerosis: rationale and results.
    Dau PC
    J Clin Apher; 1991; 6(4):200-4. PubMed ID: 1816240
    [No Abstract]   [Full Text] [Related]  

  • 4. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
    Wirguin I; Shinar E; Abramsky O
    J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen deficiency and thrombosis after plasmapheresis therapy for multiple sclerosis.
    Smith CD; Latortue R; McFarland JG; Menitove JE
    Neurology; 1986 Oct; 36(10):1410-1. PubMed ID: 3762956
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmapheresis in acute phase of multiple sclerosis].
    Matsuo H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():191-5. PubMed ID: 26480699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic apheresis in multiple sclerosis].
    Nomura K
    Nihon Rinsho; 2003 Aug; 61(8):1388-95. PubMed ID: 12962028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
    Jyoichi T; Kamegai M; Noda Y; Shimojo S; Miyahara T
    Rinsho Shinkeigaku; 1986 Sep; 26(9):907-9. PubMed ID: 3791770
    [No Abstract]   [Full Text] [Related]  

  • 11. Scientific overview of multiple sclerosis.
    Walker JE
    Prog Clin Biol Res; 1982; 106():233-7. PubMed ID: 6757942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S; Hohlfeld R
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis].
    Neretin VIa; Kir'iakova VA; Sapfirova VA; Ivanov MI; Volkova EK
    Sov Med; 1988; (2):86-9. PubMed ID: 3388103
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis in multiple sclerosis: preliminary study.
    Weiner HL; Dawson DM
    Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasmapheresis in acute phase of multiple sclerosis and neuromyelitis optica].
    Matsuo H
    Nihon Rinsho; 2014 Nov; 72(11):1999-2002. PubMed ID: 25518384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood multiple sclerosis treated with plasmapheresis.
    Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
    Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in multiple sclerosis: preliminary findings.
    Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
    Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.